指南与共识临床试验与 GCP

直肠癌新辅助放化疗成人渐进式运动干预可行性试验不可行及未来建议

An exercise trial for adults undergoing neoadjuvant chemoradiotherapy for rectal cancer proves not feasible: recommendations for future trials.
指南 / 共识 · Trials · 2021-01-06

该前瞻性单臂可行性试验原计划招募接受新辅助放化疗的直肠癌成人,评估12周渐进式运动干预的安全性和可行性。开放招募8个月后无法成功入组,修改入选标准和招募程序后仍因招募率低和样本量不足而失败,结论为试验不可行,建议未来设计时仔细考虑招募策略、沟通和试验地点等要素。

要点

  • 该12周渐进式运动干预试验因招募失败被判定不可行。
  • 开放招募8个月后无法入组,修改标准与程序后仍未能达到所需样本量。
  • 未来试验需提前仔细考虑招募策略、沟通和试验地点等要素。

核心结论

  • 该前瞻性单臂可行性试验不可行,主要因招募率低和未能入组所需样本量。
  • 建议未来设计试验前仔细考虑招募策略、沟通和试验地点等要素;若仍存在问题,试验结果风险受损,应考虑替代方案。

研究设计与样本

  • 前瞻性单臂可行性试验,原计划在12个月内招募接受新辅助放化疗的直肠癌成人。
  • 干预为12周渐进式运动干预,由训练有素的运动专家每周监督3次。
  • 开放招募8个月后修改入选标准和招募程序,并增加确定运动干预最佳时机的研究目标。

主要发现

  • 开放招募8个月后未能成功入组患者。
  • 修改入选标准和招募程序后,招募率低和样本量不足等问题仍持续阻碍试验进展。

临床怎么用

  • 未来开展类似运动干预试验前,应提前仔细评估招募策略、沟通方式和试验地点等可行性要素。

局限性

  • 试验因招募失败未能入组所需样本量,结果可靠性受损。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this paper is to share the methodological problems of an unsuccessful prospective single-arm feasibility trial conducted to evaluate the safety and feasibility of a 12-week progressive exercise intervention for adults undergoing neoadjuvant chemoradiotherapy for rectal cancer, as well as offer recommendations for future trials. METHODS: The initial plan was to recruit adults diagnosed with rectal cancer and scheduled for neoadjuvant chemoradiotherapy over a 12-month period. The exercise intervention was to consist of supervised exercise sessions delivered three times per week by a trained exercise specialist. Feasibility (i.e., recruitment, adherence, and compliance rates) and safety (i.e., adverse events) were to be assessed throughout the trial, and patient-reported and physical health outcomes were to be assessed pre- and post-intervention. After 8 months of open recruitment, we had been unable to successfully enroll patients into our trial. We therefore modified our eligibility criteria to increase the number of patients that could be recruited into our trial, and in turn increase our recruitment rate. We also amended our recruitment procedures to ensure we could reach patients who were either awaiting treatment, receiving treatment, or had completed treatments in the past 5 years. In doing so, we added a research objective, namely to determine the optimal timing of conducting an exercise intervention with adults diagnosed with rectal cancer (i.e., during neoadjuvant treatment, after surgery, during adjuvant treatment, or post-treatment). RESULTS: Many problems continued to hinder the progress of our trial, particularly the low recruitment rate and the failure to enroll the required sample size that would make our results reliable. CONCLUSION: This led us to conclude that our trial was not feasible and that it is advisable to consider some elements carefully (e.g., recruitment strategies, communication, and trial location) before designing and conducting future trials. If one or more of these elements still proves to be problematic, trial results risk being compromised and alternative approaches should be considered. TRIAL REGISTRATION: ClinicalTrials.gov NCT03049124 . Registered on 02 September 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Brunet J, Price J, Delluc C, et al. An exercise trial for adults undergoing neoadjuvant chemoradiotherapy for rectal cancer proves not feasible: recommendations for future trials. Trials. 2021. PMID: 33407782. doi:10.1186/s13063-020-04958-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。